Corvus Pharmaceuticals CRVS Institutional Ownership

NASDAQ CRVS

$11.52 -0.24 (-2.04%)

At close: Sep 30, 2026 · 4:00 PM EDT

Institutions by Trading Activity

176 Institutions

Increased 114 64.8%

Unchanged 22 12.5%

Reduced 40 22.7%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

76.79%

▼-0.96 pp QoQ

Shares Held by Institutions

70.93Mn

of 92.37Mn outstanding

▲+12.45% QoQ

Shares Outstanding

92.37Mn

21.43Mn held outside 13F filers

Institutional Investors

176

filed 13F for Jun 2026

▲+12 vs prior quarter

Net Shares Added (QoQ)

+7.85Mn

accumulated since last quarter

Value of Holdings

$817.16Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) is held by 176 institutional investors per 13F filings through June 2026.

These investors held 76.8% of outstanding shares in June 2026, down from 77.8% in March 2026.
Their total shares held in CRVS increased 12.45% quarter over quarter, and separately, investors owning Corvus Pharmaceuticals increased 93.41% from a year ago.
Activity in CRVS broke down as 114 buyers, 40 sellers, and 22 unchanged among 176 total holders.
The aggregate institutional position in Corvus Pharmaceuticals amounted to 70.93Mn shares as of June 2026, up by 7.85Mn shares quarter on quarter, and up 30.06Mn shares year over year.
As of June 30, 2026, ORBIMED ADVISORS LLC held the largest stake in Corvus Pharmaceuticals with 7.17Mn shares, accounting for 7.76% of total shares outstanding.
The largest buyers of Corvus Pharmaceuticals for the quarter ending June 2026 were BlackRock, Inc. (978.39K), State Street Corp (908.1K), PRICE T ROWE ASSOCIATES INC /MD/ (871.83K), Eversept Partners, LP (747.99K), Bank Of America Corp /De/ (520.79K).
The largest sellers of Corvus Pharmaceuticals for the quarter ending June 2026 were Morgan Stanley (1.15Mn), MARSHALL WACE, LLP (447.81K), Squarepoint Ops LLC (79.69K), CITADEL ADVISORS LLC (44.57K), TD ASSET MANAGEMENT INC (41.14K).
Per Business Quant data, the top 10 holders of Corvus Pharmaceuticals for the quarter ending June 2026 are ORBIMED ADVISORS LLC (7.17Mn), BlackRock, Inc. (7.14Mn), State Street Corp (4.47Mn), PRICE T ROWE ASSOCIATES INC /MD/ (3.79Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.29Mn), ADAMS STREET PARTNERS LLC (3.28Mn), Vivo Capital, LLC (2.81Mn), WELLINGTON MANAGEMENT GROUP LLP (2.73Mn), PERCEPTIVE ADVISORS LLC (2.67Mn), Deep Track Capital, LP (2.49Mn).

Form 13F Holdings

176 Institutional Holders

Report period 30 Jun, 2026

Total shares held 70.93Mn

Of outstanding 76.79%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	ORBIMED ADVISORS LLC	0001055951	7,165,006	7.76%	0	0.00%	$107.05Mn
2	BlackRock, Inc.	0002012383	7,138,811	7.73%	▲978,389	+15.88%	$106.65Mn
3	State Street Corp	0000093751	4,474,091	4.84%	▲908,099	+25.47%	$66.84Mn
4	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	3,789,126	4.10%	▲871,826	+29.88%	$56.61K
5	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	3,292,710	3.56%	▲58,172	+1.80%	$49.19Mn
6	ADAMS STREET PARTNERS LLC	0001193586	3,275,616	3.55%	0	0.00%	$48.94Mn
7	Vivo Capital, LLC	0001674712	2,805,816	3.04%	0	0.00%	$41.92Mn
8	WELLINGTON MANAGEMENT GROUP LLP	0000902219	2,731,632	2.96%	▲413,115	+17.82%	$40.81Mn
9	PERCEPTIVE ADVISORS LLC	0001224962	2,667,441	2.89%	▲375,000	+16.36%	$39.85Mn
10	Deep Track Capital, LP	0001856083	2,491,939	2.70%	▲400	+0.02%	$37.23Mn
11	BRAIDWELL LP	0001920938	2,126,298	2.30%	▲373,500	+21.31%	$31.77Mn
12	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,853,659	2.01%	▲140,918	+8.23%	$27.70Mn
13	Foresite Capital Management VI LLC	0002013341	1,831,233	1.98%	0	0.00%	$27.36Mn
14	Goldman Sachs Group Inc	0000886982	1,576,352	1.71%	▲35,543	+2.31%	$23.55Mn
15	Hood River Capital Management LLC	0001578177	1,571,805	1.70%	▲236,696	+17.73%	$23.48Mn
16	Morgan Stanley	0000895421	1,344,736	1.46%	▼1,154,089	-46.19%	$20.09Mn
17	Boxer Capital Management, LLC	0002018299	1,100,000	1.19%	0	0.00%	$16.43Mn
18	Catalio Capital Management, LP	0001958125	1,080,888	1.17%	▲188,955	+21.18%	$16.15Mn
19	MILLENNIUM MANAGEMENT LLC	0001273087	1,047,985	1.13%	▲181,623	+20.96%	$15.66Mn
20	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	814,750	0.88%	▲144,855	+21.62%	$12.17Mn

Showing 1 to 20 of 176 holders